S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab
暂无分享，去创建一个
G. Ferry | J. Boutin | J. Hickman | P. Comoglio | S. Depil | C. Bossard | F. Bouzom | A. Cordi | F. Cruzalegui | I. Fejes | S. Léonce | B. Lockhart | Georges Da Violante | V. Cattan | M. Burbridge | A. Jacquet-Bescond | A. Bruno | C. Saunier | A. Pierré | J. Ortuno | S. Léonce